Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Purpose

Endovascular aortic repair (EAR) interventions, endovascular abdominal aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR), are associated with significant radiation exposures. We aimed to investigate the radiation doses from real-world practice and propose diagnostic reference level (DRL) for the UK.

Materials and methods

Radiation data and essential demographics were retrospectively collected from 24 vascular and interventional radiology centres in the UK for all patients undergoing EAR-standard EVAR or complex, branched/fenestrated (BEVAR/FEVAR), and TEVAR-between 2018 and 2021. The data set was further categorised according to X-ray unit type, either fixed or mobile. The proposed national DRL is the 75th percentile of the collective medians for procedure KAP (kerma area product), cumulative air kerma (CAK), fluoroscopy KAP and CAK.

Results

Data from 3712 endovascular aortic procedures were collected, including 2062 cases were standard EVAR, 906 cases of BEVAR/FEVAR and 509 cases of TEVAR. The majority of endovascular procedures (3477/3712) were performed on fixed X-ray units. The proposed DRL for KAP was 162 Gy cm2, 175 Gy cm2 and 266 Gy cm2 for standard EVAR, TEVAR and BEVAR/FEVAR, respectively.

Conclusion

The development of DRLs is pertinent to EAR procedures as the first step to optimise the radiation risks to patients and staff while maintaining the highest patient care and paving the way for steps to reduce radiation exposures.

Free full text 


Cardiovasc Intervent Radiol. 2024; 47(1): 92–100.
Published online 2023 Nov 15. https://doi.org/10.1007/s00270-023-03592-x
PMCID: PMC10770209
PMID: 37968425

National UK Survey of Radiation Doses During Endovascular Aortic Interventions

Abstract

Purpose

Endovascular aortic repair (EAR) interventions, endovascular abdominal aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR), are associated with significant radiation exposures. We aimed to investigate the radiation doses from real-world practice and propose diagnostic reference level (DRL) for the UK.

Materials and Methods

Radiation data and essential demographics were retrospectively collected from 24 vascular and interventional radiology centres in the UK for all patients undergoing EAR—standard EVAR or complex, branched/fenestrated (BEVAR/FEVAR), and TEVAR—between 2018 and 2021. The data set was further categorised according to X-ray unit type, either fixed or mobile. The proposed national DRL is the 75th percentile of the collective medians for procedure KAP (kerma area product), cumulative air kerma (CAK), fluoroscopy KAP and CAK.

Results

Data from 3712 endovascular aortic procedures were collected, including 2062 cases were standard EVAR, 906 cases of BEVAR/FEVAR and 509 cases of TEVAR. The majority of endovascular procedures (3477/3712) were performed on fixed X-ray units. The proposed DRL for KAP was 162 Gy cm2, 175 Gy cm2 and 266 Gy cm2 for standard EVAR, TEVAR and BEVAR/FEVAR, respectively.

Conclusion

The development of DRLs is pertinent to EAR procedures as the first step to optimise the radiation risks to patients and staff while maintaining the highest patient care and paving the way for steps to reduce radiation exposures.

Keywords: Diagnostic reference level, Endovascular aortic aneurysm repair, Radiation protection, Aorta, Radiation dose

Introduction

Endovascular aneurysm repair (EAR) interventions—endovascular abdominal aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR)—have become routine practice owing to their minimally invasive nature, shorter admission times and a lower rate of short-term complications compared to open repair [1].

Due to the potentially complex nature of EAR interventions, high radiation doses can be expected [24]. Therefore, optimising the dose-image quality balance is key for staff and patient safety. To aid the process of optimisation, the International Commission on Radiological Protection (ICRP) has developed the term diagnostic reference level (DRL) [5]. This is a value of procedure dose to the patient, normally expressed as both a kerma area product (KAP) and fluoroscopy time, determined from median values at a wide range of facilities, that seeks to guide centres in understanding whether their doses are high and if so, investigate if patient doses may be lowered. Most radiological examinations have nationally agreed DRLs to guide optimisation. However, there is a lack of DRLs for interventional procedures in the UK and other European countries.

The following confounding factors should be considered to develop DRLs relevant to aortic interventions. The term EAR covers a wide range of interventions, from standard EVARs to more complex fenestrated endovascular abdominal aortic repair (FEVAR), branched endovascular aortic repair (BEVAR) and TEVAR interventions. Furthermore, the manufacturer, model, type (fixed vs mobile theatre C-arm) and age of imaging equipment play key roles in determining the patient dose. Tuthill and colleagues proposed an interim European DRL [6], and a local DRL was proposed in European countries such as Spain and Greece [4, 7]. The UK does not presently have a nationally accepted DRL for such interventions. This realisation drove us to recruit centres across the UK to survey current dose levels and propose national DRLs.

In this national survey, we aimed to provide national DRLs so individual departments may optimise their practices and provide lower radiation exposure to patients and staff and discuss the differences in doses due to differing subcategories of EAR interventions and the X-ray equipment used.

Materials and Methods

This retrospective study contains data collected from joint interventional and vascular centres in the UK for all patients undergoing EVAR (standard or branched/fenestrated) and TEVAR between 2018 and 2021. Centres included a range of regional teaching hospitals and local general hospitals, located in England, Wales and Scotland. Ethical approval for this retrospective study was waived according to institutional guidelines. Due to the study’s retrospective, anonymised, noninterventional nature based solely on data generated and documented during clinical practice, informed and written consent was not required.

In total, 27 out of the 67 Interventional and Vascular Surgery centres in the UK, according to the National Vascular Registry (NVR), were emailed requesting data. The data requested included age, sex, type of procedure and date, X-ray unit model, procedure KAP, fluoroscopy time, cumulative air kerma (CAK) and fluoroscopy KAP and CAK. Data were collected from electronic patient notes, picture archiving and communication systems (PACS) and angiographic systems, as well as patient dose management systems where available.

The data set was divided into standard EVAR, FEVAR/B EVAR and TEVAR and further categorised according to X-ray unit type (i.e. fixed or mobile). Each X-ray unit was analysed separately to form the distribution of device medians. All data provided, irrespective of procedure outcome, were included in statistical analysis, which was carried out using SPSS Statistics 27. Normality tests were performed, and medians and boxplots were used because the data were nonparametric. The proposed national DRL is the 75th percentile of the collected medians [5], of centres with five or more cases. The data were presented in graphs in the order of ascending medians, and the centres’ names were anonymised into numbers.

Results

Data from 3712 endovascular aortic procedures were collected from 24 centres, out of which 6 were local general hospitals and 18 were regional teaching hospitals. The mean age was 74.6 (± 10.0 SD) years old, and 84.2% were males and 15.8% were females. The majority of endovascular procedures, 3477/3712, were performed on fixed X-ray units, and 235/3712 were performed on mobile units. Of those performed on fixed units, 2062 cases were standard EVAR, 906 were BEVAR/FEVAR, and 509 were TEVAR. Of those performed on mobile units, 129 were standard EVAR, 106 cases were BEVAR/FEVAR, and 26 were TEVAR. All data provided underwent a quality assurance review, where if any centres provided data that were outside of expected values, they were emailed to clarify the units provided. Due to the retrospective nature of the study, some data sets were incomplete; however, all data were further analysed.

Figure 1 demonstrates the KAP medians and boxplots performed on fixed machines for standard EVAR procedures in ascending order. The 75th percentile of the medians was 162 Gy cm2. Figure 2 demonstrates the KAP medians and boxplots of complex endovascular procedures, BEVAR and FEVAR, performed on fixed machines. The 75th percentile of the medians was 266 Gy cm2 (5 centres excluded). Figure 3 demonstrates the KAP medians and boxplots of TEVAR procedures on fixed machines. The 75th percentile of the medians was 175 Gy cm2 (1 centres excluded) (Fig. 3).

An external file that holds a picture, illustration, etc.
Object name is 270_2023_3592_Fig1_HTML.jpg

The median KAP and boxplots of standard EVAR on fixed X-ray units in ascending order. The 75th percentile of the medians was 162 Gy cm2 as demonstrated by the black horizontal line. Circles indicate outliers and asterisks extreme outliers in all graphs

An external file that holds a picture, illustration, etc.
Object name is 270_2023_3592_Fig2_HTML.jpg

The median KAP and boxplots of BEVAR/FEVAR on fixed X-ray units in ascending order. The 75th percentile of the medians was 266 Gy cm2 as demonstrated by the black horizontal line. Centres with fewer than 5 cases are included in this graph

An external file that holds a picture, illustration, etc.
Object name is 270_2023_3592_Fig3_HTML.jpg

The median KAP and boxplots of TEVAR on fixed X-ray units in ascending order. The 75th percentile of the medians was 175 Gy cm2 as demonstrated by the black horizontal line

For standard EVAR, the CAK 75th percentile was 865 mGy, and the fluoroscopy KAP 75th percentile was 49 Gy cm2 (Fig. 4). The fluoroscopy CAK was provided by 6 centres, and therefore, a DRL was not calculated. For BEVAR/FEVAR, the CAK 75th percentile was 1390 mGy (4 centres excluded), and the fluoroscopy KAP 75th percentile was 190 Gy cm2 (2 centres excluded) (Fig. 5). The fluoroscopy CAK was provided by 6 centres, ranging from 7 to 213 mGy. For TEVAR, the CAK was reported by 7 centres, ranging from 202 to 1050 mGy; fluoroscopy KAP by 5 centres, ranging from 1.9 to 18.9 Gy cm2; and the fluoroscopy CAK by 3 centres, ranging from 8 to 86 mGy. Due to the limited number of centres, no DRL was calculated for the above.

An external file that holds a picture, illustration, etc.
Object name is 270_2023_3592_Fig4_HTML.jpg

a The median CAK and boxplots of standard EVAR on fixed X-ray units in ascending order. The 75th percentile of the medians was 865 mGy as demonstrated by the black horizontal line. b The median fluoroscopy KAP and boxplots of standard EVAR on fixed X-ray units in ascending order. The 75th percentile of the medians was 49 Gy cm2 as demonstrated by the black horizontal line

An external file that holds a picture, illustration, etc.
Object name is 270_2023_3592_Fig5_HTML.jpg

a The median CAK and boxplots of BEVAR/FEVAR on fixed. The 75th percentile of the medians was 1390 mGy as demonstrated by the black horizontal line. Centres with < 5 cases are included in this graph. b The median fluoroscopy KAP and boxplots of BEVAR/FEVAR on fixed. The 75th percentile of the medians was 190 Gy cm2 as demonstrated by the black horizontal line. Centres with < 5 cases are included in this graph

For standard EVAR procedures on mobile X-ray units, only 6 out of the 10 centres providing data on KAP had 5 or more procedures. Similarly, the CAK was only provided by 2 centres. Hence, no national DRL was proposed. Due to the small number of TEVAR cases carried out on mobiles and the majority of BEVAR/FEVAR mobile cases being from a single centre, no national DRL was proposed.

The 75th percentile of the medians for the fluoroscopic time in minutes, shown in Fig. 6, for standard EVAR, BEVAR/FEVAR and TEVAR on fixed machines was 24.8, 61.7 (4 centres excluded) and 12.1 min (2 centres excluded), respectively.

An external file that holds a picture, illustration, etc.
Object name is 270_2023_3592_Fig6_HTML.jpg

The median fluoroscopy time in minutes and boxplots of a standard EVAR, b BEVAR/FEVAR and c TEVAR on fixed X-ray units, in ascending order. The 75th percentile of the medians was 24.8 min, 61.7 min and 12.1 min as demonstrated by the black horizontal line in each respective graph. Centres with < 5 cases are included in the graphs

Discussion

With the increasing number of interventional radiology procedures, the population dose also increases [8]. The ICRP and Society of Interventional Radiology recommend the formation and use of DRLs in interventional radiology to improve dose monitoring and management [5, 9, 10]. Specifically, the IRCP (in its publication 135) acknowledges that radiation doses can vary greatly even within the same department for the same procedure, as demonstrated in our study; therefore, implementation can be challenging [5, 11]. Additionally, the European Directive 2013/59/EURATOM requires its member states to establish and utilise DRLs in interventional radiology, with regular reviews [12]. This requirement was transposed into UK regulations by the Ionising Radiation (Medical Exposure) Regulations 2017 [13] and amended in 2018 (UK SI) [14].

Although a DRL is typically defined as the standard dose for a standard-sized patient [5, 12], our data make it clear that doses vary greatly across the UK and within each procedure category. Comparing our data to NVR, patient demographics were similar with 88% and 83% of patients undergoing EVAR and complex being male during 2019–2021, respectively. This study represents close to 40% of NVR cases [15]. Therefore, regular DRL review through a multicentre approach is necessary to keep DRLs updated with ever-advancing technological and clinical practice. Regular audits and reviews will allow local centres to understand their patient doses in a national context to use this information to optimise their procedures, implement up-to-date DRLs and maintain quality assurance. This will help to keep patient doses as low as reasonably achievable (ALARA) [5].

Inter-centre dose discrepancies are multifactorial and may result from nonoptimised fluoroscopic-guided procedures. Nonexhaustive parameters affecting dose include operator experience [1618], equipment age, dose display with automatic dose monitoring, and further technical factors such as pulse rate, collimation, angulation, magnification, patient size, procedural complexity, state-of-the-art facilities incorporating updated technology and optimised automatically applied settings, all cumulatively reducing the dose [19].

The dose should be minimised while maintaining image quality to allow for optimal patient outcomes. Image fusion (preoperative CT angiography with live fluoroscopy image fusion) has also been extensively shown to reduce the radiation dose [3, 20, 21], contrast volume and procedural time during EVAR [22], with vessel navigation possible without contrast bolus. A few additional factors have been suggested that may also contribute to dose discrepancies (that were not accounted for in our study). One example includes the potential overestimation of KAP due to attenuation by the table and mattress. This may be up to 40% on some systems [23]. However, although KAP displays are often calibrated ‘in air’, one would expect local centres to have systems to adjust these readings to allow for more accurate dose measurement. Furthermore, not all angulations intercept the table, so the amount of overestimation is likely to be less [23]. The latest image-processing techniques that reduce visible noise also allow for significantly lower patient doses [24].

International guidelines suggest patients follow up for skin doses above 5 Gy (CAK) or 500 Gy cm2 (KAP) to monitor for radiation-induced skin injury [10]. None of the procedures exceeded 5 Gy for CAK; however, out of the standard EVAR, BEVAR/FEVAR and TEVAR, 2.8%, 14.0% and 5.7% exceeded 500 Gy cm2 for KAP on fixed machines, respectively. Patients undergoing endovascular aneurysm repair frequently require follow-up imaging and possible re-intervention, increasing the patients’ annual dose, with endoleaks as a potential complication. Consideration should also be made for the same skin or organ in-field dose being re-irradiated. Centres should have robust procedures in place for the management of high-risk patients and those who exceed trigger levels. Identification of at-risk patients is well described by Jaschke et al. [25] and includes patients who undergo repeated procedures, radiotherapy on the same entry site and weight greater than 120 kg.

Our results show an approximately 3 times reduction in KAP for standard EVAR procedures when carried out on a mobile X-ray unit compared to a fixed X-ray unit. This ratio is comparable with some recent literature [4]. There is quality of care when using mobile X-ray units in aortic interventions; however, this has been criticised by both the Royal College of Radiologists and Medicines and Healthcare products Regulatory Agency (MHRA) [26, 27]. Since few centres still need to use mobile X-ray units for some procedures, we have included the results.

Comparing our data to the proposed interim DRLs by Tuthil and colleagues, the cohort of patients was much smaller, with a total of 180 standard EVAR procedures from 5 centres with similar demographics to this study. Their 75th percentile value KAP was 158.49 Gy cm2 for standard EVAR, which is only slightly smaller compared to our study. In contrast, the 75th percentile for the fluoroscopic time was 18.1 min compared to the 24.8 min reported in our study [6].

Our findings and previous papers demonstrate a strong correlation between complexity within endovascular work with dose and fluoroscopy time [7, 28]. Fluoroscopy time, however, is not necessarily correlated with increased doses [2931]. Although we have not implemented complexity scoring systems or performed complexity subgrouping analyses, our data support the aforementioned correlation between dose and complexity, with fixed machine analysis demonstrating the following: KAP for standard EVAR (162 Gy cm2), TEVAR (175 Gy cm2) and BEVAR/FEVAR (266 Gy cm2) and fluoroscopy KAP for standard EVAR (49 Gy cm2) BEVAR/FEVAR (190 Gy cm2).

Our cases only included joint IR procedures to ensure a homogenous group of operators with the same level of expertise, training and understanding of radiation protection measures. We have not analysed subgroups comparing independent vascular surgeons versus IR endovascular aneurysm repair doses, as the setup varies across all UK centres. Our study pooled data from all centres into the 3 data sets: standard EVAR, FEVAR/BEVAR and TEVAR. This study’s main limitation is the retrospective data collection, which meant that some patient demographics and variables were unavailable, such as weight and height, CAK, number of runs/acquisitions and number of angles. However, a few studies suggest DRLs can be calculated without the need to acknowledge patient weight [32, 33]. Although our data collection had limited data on weight, the study recorded all patients and is thus representative of the whole patient cohort rather than a weight-determined subset or attempts to normalise our dose metrics by a weight-derived value. Retrospective data collection also necessitated a manual review of multicentre case descriptors, allowing for unrelated cases to be identified and removed from the data set following discussions with the project leads. Similar issues have been described in numerous similar studies for DRL establishment within interventional radiology [19, 34]. Future reviews of DRL implementation and procedural doses should ideally be a prospective analysis, with automated data transfer and advancing dosimetric software to avoid human error and allow accurate data validation. A barrier to implementing this would be the difficulty arising from incorrect or inadequate system coding of procedures. All centres should develop and adopt guidance whereby coding and electronic dose-capturing systems are consistent. Although dose optimisation through the use of DRLs and the ALARA principle is paramount, this should not affect the image quality or procedural outcome.

Conclusion

The proposed DRL for KAP was 162 Gy cm2, 175 Gy cm2 and 266 Gy cm2 for standard EVAR, TEVAR and BEVAR/FEVAR, respectively. This study shows that endovascular aortic procedures can be associated with significant radiation doses and that there are large inter-centre dose variations. Developing DRLs pertinent to those procedures is essential to optimise the radiation risks to patients and staff while maintaining the highest standard of patient care.

Acknowledgements

The authors want to tahnk the RADEVAIR Collaborators. This work was supported by Imperial College London Healthcare Biomedical Research Centre.

RADEVAIR (RAdiation Doses in EndoVascular Aortic InteRventions) Collaborators:

Lamran Khan1, Ananth Krishnan1, Martin Hennessy2, Ram Kasthuri2, Zenaib Al-Rekabi2, Said Abisi3, Mark Hampshire3, Panos Goutzios3, Muhammad Hanif4, Emma Olivier5, Andrew Wood5, Andrew Macey6, Sachin Modi6, Robert Allison6, Clare Bent7, Peter Bungay8, Robert Whiteman8, Robin Williams9, Zaid Aldin11, Josephine Weaver10, Robert Kaikini11, David Wells12, John Hancock13, Anil Madhavan14, Sapna Puppala15, Matthew Matson16, Katharine Lewis17, Raman Uberoi18, Andrew Winterbottom19, Bella Huasen20, Michael Jenkins21, Trevor Cleveland22, Rachel Butcher22

1Manchester University NHS Foundation Trust, United Kingdom; 2Glasgow Royal Infirmary, United Kingdom; 3Guy's and St Thomas' NHS Foundation Trust, United Kingdom; 4Mid and South Essex NHS Foundation Trust, United Kingdom; 5Cardiff and Vale University Health Board, United Kingdom; 6Southampton General Hospital, United Kingdom; 7University Hospitals Dorset NHS Foundation Trust, United Kingdom; 8Royal Derby Hospital, United Kingdom; 9The Newcastle Upon Tyne Hospitals NHS Foundation Trust, United Kingdom; 10The Princess Alexandra Hospital , United Kingdom; 11East Kent Hospitals University NHS Foundation Trust, United Kingdom; 12Royal Stoke University Hospital, United Kingdom; 13Royal Cornwall Hospitals NHS Foundation Trust, United Kingdom; 14Medway NHS Foundation Trust, United Kingdom; 15Leeds Teaching Hospitals NHS Trust, United Kingdom; 16Royal London Hospital and Barts NHS Trust, United Kingdom; 17Somerset NHS Foundation Trust, United Kingdom; 18Oxford University Hospitals, United Kingdom; 19Addenbrooke's Hospital, United Kingdom; 20Lancashire Teaching Hospitals NHS Foundation Trust, United Kingdom; 21Imperial College Healthcare NHS Trust, St. Mary’s Hospital, London, UK; 22Sheffield teaching Hospital NHS Foundation Trust, United Kingdom

Funding

This study was not supported by any funding.

Declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Consent for Publication

For this type of study consent for publication is not required.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Informed Consent

For this type of study informed consent is not required.

Footnotes

The original online version of this article was revised: In the original text, in the list of RADEVAIR Collaborators (page 8) Emma Olivier’s name was misspelled as Emma Oliver.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Yvonne Tsitsiou, Bar Velan and Rebecca Ross have contributed equally to this work.

Change history

12/12/2023

A Correction to this paper has been published: 10.1007/s00270-023-03632-6

References

1. Sweeting MJ, Patel R, Powell JT, Greenhalgh RM. Endovascular repair of abdominal aortic aneurysm in patients physically ineligible for open repair. Ann Surg. 2017;266(5):713–719. 10.1097/SLA.0000000000002392. [Abstract] [CrossRef] [Google Scholar]
2. Foerth M, Seidenbusch MC, Sadeghi-Azandaryani M, Lechel U, Treitl KM, Treitl M. Typical exposure parameters, organ doses and effective doses for endovascular aortic aneurysm repair: comparison of Monte Carlo simulations and direct measurements with an anthropomorphic phantom. Eur Radiol. 2015;25(9):2617–2626. 10.1007/s00330-015-3673-8. [Abstract] [CrossRef] [Google Scholar]
3. Hertault A, Rhee R, Antoniou GA, Adam D, Tonda H, Rousseau H, et al. Radiation dose reduction during EVAR: results from a prospective multicentre study (The REVAR Study) Eur J Vasc Endovasc Surg. 2018;56(3):426–433. 10.1016/j.ejvs.2018.05.001. [Abstract] [CrossRef] [Google Scholar]
4. Rial R, Vañó E, Del Río-Solá ML, Fernández JM, Sánchez RM, Camblor Santervás LA, et al. National diagnostic reference levels for endovascular aneurysm repair and optimisation strategies. Eur J Vasc Endovasc Surg. 2020;60(6):837–842. 10.1016/j.ejvs.2020.08.006. [Abstract] [CrossRef] [Google Scholar]
5. Vañó E, Miller DL, Martin CJ, Rehani MM, Kang K, Rosenstein M, et al. ICRP publication 135: diagnostic reference levels in medical imaging. Ann ICRP. 2017;46(1):1–144. 10.1177/0146645317717209. [Abstract] [CrossRef] [Google Scholar]
6. Tuthill E, O’Hora L, O’Donohoe M, Panci S, Gilligan P, Campion D, et al. Investigation of reference levels and radiation dose associated with abdominal EVAR (endovascular aneurysm repair) procedures across several European Centres. Eur Radiol. 2017;27(11):4846–4856. 10.1007/s00330-017-4791-2. [Abstract] [CrossRef] [Google Scholar]
7. Tzanis E, Ioannou CV, Tsetis D, Lioudaki S, Matthaiou N, Damilakis J. Complexity-based local diagnostic reference levels (DRLs) for standard endovascular aneurysm repair (EVAR) procedures. Phys Med PM Int J Devoted Appl Phys Med Biol. 2020;73:89–94. 10.1016/j.ejmp.2020.04.015. [Abstract] [CrossRef] [Google Scholar]
8. European Society of Radiology (ESR) Summary of the proceedings of the International Forum 2017: ‘position of interventional radiology within radiology’ Insights Imaging. 2018;9(2):189–197. 10.1007/s13244-018-0594-5. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
9. Christofides S, Isidoro J, Pesznyak C, Bumbure L, Cremers F, Schmidt WFO. The European Federation of Organisations for Medical Physics Policy Statement No. 6.1: recommended guidelines on national registration schemes for medical physicists. Phys Med. 2016;32(1):1–6. 10.1016/j.ejmp.2016.01.479. [Abstract] [CrossRef] [Google Scholar]
10. Stecker MS, Balter S, Towbin RB, Miller DL, Vañó E, Bartal G, et al. Guidelines for patient radiation dose management. J Vasc Interv Radiol. 2009;20(7):S263–S273. 10.1016/j.jvir.2009.04.037. [Abstract] [CrossRef] [Google Scholar]
11. Rizk C, Farah J, Vanhavere F, Fares G. National diagnostic reference levels in interventional radiology suites in Lebanon: a multicenter survey. Radiat Prot Dosimetry. 2019;187(1):50–60. 10.1093/rpd/ncz137. [Abstract] [CrossRef] [Google Scholar]
12. European Parliament. Council Directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom a. Off J Eur Commun L13. 2014;(December 2003):1–73.
13. Gov.uk. 2017. Ionising Radiation (Medical Exposure) Regulations 2017 (IRMER). https://www.gov.uk/government/publications/ionising-radiation-medical-exposure-regulations-2017-guidance. Accessed 25 Apr 2023.
14. Gov.uk. 2018. Ionising Radiation (Medical Exposure) (Amendment) Regulations 2018. https://www.gov.uk/government/publications/ionising-radiation-medical-exposure-regulations-2017-guidance. Accessed 25 Apr 2023.
15. Waton S, Johal A, Birmpili P, Li Q, Atkins E, Cromwell DA, Williams R, Pherwani AD. National Vascular Registry: 2022 annual report. London: The Royal College of Surgeons of England; 2022. [Google Scholar]
16. Fetterly KA, Lennon RJ, Bell MR, Holmes DR, Rihal CS. Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician. JACC Cardiovasc Interv. 2011;4(3):336–343. 10.1016/j.jcin.2010.10.014. [Abstract] [CrossRef] [Google Scholar]
17. Ruiz-Cruces R, Vano E, Carrera-Magariño F, Moreno-Rodriguez F, Soler-Cantos MM, Canis-Lopez M, et al. Diagnostic reference levels and complexity indices in interventional radiology: a national programme. Eur Radiol. 2016;26(12):4268–4276. 10.1007/s00330-016-4334-2. [Abstract] [CrossRef] [Google Scholar]
18. Etard C, Bigand E, Salvat C, Vidal V, Beregi JP, Hornbeck A, et al. Patient dose in interventional radiology: a multicentre study of the most frequent procedures in France. Eur Radiol. 2017;27(10):4281–4290. 10.1007/s00330-017-4780-5. [Abstract] [CrossRef] [Google Scholar]
19. Schegerer AA, Frija G, Paulo G, Jaschke W, Tsapaki V, Repussard J, et al. Radiation dose and diagnostic reference levels for four interventional radiology procedures: results of the prospective European multicenter survey EUCLID. Eur Radiol. 2021;31(12):9346–9360. 10.1007/s00330-021-08029-y. [Abstract] [CrossRef] [Google Scholar]
20. Swerdlow NJ, Wu WW, Schermerhorn ML. Open and endovascular management of aortic aneurysms. Circ Res. 2019;124(4):647–661. 10.1161/CIRCRESAHA.118.313186. [Abstract] [CrossRef] [Google Scholar]
21. de Ruiter QMB, Reitsma JB, Moll FL, van Herwaarden JA. Meta-analysis of cumulative radiation duration and dose during EVAR using mobile, fixed, or fixed/3D fusion C-arms. J Endovasc Ther. 2016;23(6):944–956. 10.1177/1526602816668305. [Abstract] [CrossRef] [Google Scholar]
22. Goudeketting SR, Heinen SGH, Ünlü Ç, van den Heuvel DAF, de Vries J-PPM, van Strijen MJ, et al. Pros and cons of 3D image fusion in endovascular aortic repair: a systematic review and meta-analysis. J Endovasc Ther. 2017;24(4):595–603. 10.1177/1526602817708196. [Abstract] [CrossRef] [Google Scholar]
23. Bleeser F, Hoornaert M-T, Smans K, Struelens L, Buls N, Berus D, et al. Diagnostic reference levels in angiography and interventional radiology: a Belgian multi-centre study. Radiat Prot Dosimetry. 2008;129(1–3):50–55. 10.1093/rpd/ncn028. [Abstract] [CrossRef] [Google Scholar]
24. Kirkwood ML, Guild JB, Arbique GM, Tsai S, Modrall JG, Anderson JA, et al. New image-processing and noise-reduction software reduces radiation dose during complex endovascular procedures. J Vasc Surg. 2016;64(5):1357–1365. 10.1016/j.jvs.2016.04.062. [Abstract] [CrossRef] [Google Scholar]
25. Jaschke W, Bartal G, Martin CJ, Vano E. Unintended and accidental exposures, significant dose events and trigger levels in interventional radiology. Cardiovasc Interv Radiol. 2020;43(8):1114–1121. 10.1007/s00270-020-02517-2. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
26. British Society of Interventional Radiology, The Royal College of Radiologists. Provision of interventional radiology services-second edition. 2019;(September). www.rcr.ac.uk.
27. Medicines and Health Products Regulatory Agency, The Royal College of Radiologists, the British Society of Interventional Radiologists, the Vascular Society of Great Britain and Ireland, the Vascular Anaesthesia Society of Great Britain and Ireland, the Medicines and Healthcare Products Regulatory Agency Committee on the Safety of Devices. Joint working group to produce guidance on delivering an endovascular aneurysm repair (EVAR) service. London: MHRA; 2010.
28. Thakor AS, Winterbottom A, Mercuri M, Cousins C, Gaunt ME. The radiation burden from increasingly complex endovascular aortic aneurysm repair. Insights Imaging. 2011;2(6):699–704. 10.1007/s13244-011-0120-5. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
29. Fletcher DW, Miller DL, Balter S, Taylor MA. Comparison of four techniques to estimate radiation dose to skin during angiographic and interventional radiology procedures. J Vasc Interv Radiol JVIR. 2002;13(4):391–397. 10.1016/s1051-0443(07)61742-4. [Abstract] [CrossRef] [Google Scholar]
30. Miller DL, Balter S, Wagner LK, Cardella J, Clark TWI, Neithamer CD, et al. Quality improvement guidelines for recording patient radiation dose in the medical record. J Vasc Interv Radiol JVIR. 2004;15(5):423–429. 10.1097/01.rvi.0000126814.97605.c6. [Abstract] [CrossRef] [Google Scholar]
31. Balter S. Capturing patient doses from fluoroscopically based diagnostic and interventional systems. Health Phys. 2008;95(5):535–540. 10.1097/01.HP.0000327650.37315.2f. [Abstract] [CrossRef] [Google Scholar]
32. Georges J-L, Belle L, Etard C, Azowa J-B, Albert F, Pansieri M, et al. Radiation doses to patients in interventional coronary procedures-estimation of updated national reference levels by dose audit. Radiat Prot Dosimetry. 2017;175(1):17–25. 10.1093/rpd/ncw261. [Abstract] [CrossRef] [Google Scholar]
33. Miller DL, Kwon D, Bonavia GH. Reference levels for patient radiation doses in interventional radiology: proposed initial values for U.S. practice. Radiology. 2009;253(3):753–764. 10.1148/radiol.2533090354. [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
34. Pace E, Cortis K, Debono J, Grech M, Caruana CJ. Establishing local and national diagnostic and interventional cardiology and radiology reference levels in a small European State: the case of Malta. Radiat Prot Dosimetry. 2020;191(3):261–271. 10.1093/rpd/ncaa152. [Abstract] [CrossRef] [Google Scholar]

Citations & impact 


This article has not been cited yet.

Impact metrics

Alternative metrics

Altmetric item for https://www.altmetric.com/details/156561704
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/156561704